Literature DB >> 8534912

Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by Fc epsilon R1 cross-linking.

S A Barker1, K K Caldwell, A Hall, A M Martinez, J R Pfeiffer, J M Oliver, B S Wilson.   

Abstract

We have investigated the effects of wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase), on antigen-mediated signaling in the RBL-2H3 mast cell model. In RBL-2H3 cells, the cross-linking of high affinity IgE receptors (Fc epsilon R1) activates at least two cytoplasmic protein tyrosine kinases, Lyn and Syk, and stimulates secretion, membrane ruffling, spreading, pinocytosis, and the formation of actin plaques implicated in increased cell-substrate adhesion. In addition, Fc epsilon R1 cross-linking activates PI 3-kinase. It was previously shown that wortmannin causes a dose-dependent inhibition of PI 3-kinase activity and also inhibits antigen-stimulated degranulation. We report that the antigen-induced synthesis of inositol(1,4,5)P3 is also markedly inhibited by wortmannin. Consistent with evidence in other cell systems implicating phosphatidylinositol(3,4,5)P3 in ruffling, pretreatment of RBL-2H3 cells with wortmannin inhibits membrane ruffling and fluid pinocytosis in response to Fc epsilon R1 cross-linking. However, wortmannin does not inhibit antigen-induced actin polymerization, receptor internalization, or the actin-dependent processes of spreading and adhesion plaque formation that follow antigen stimulation in adherent cells. Wortmannin also fails to inhibit either of the Fc epsilon R1-coupled tyrosine kinases, Lyn or Syk, or the activation of mitogen-activated protein kinase as measured by in vitro kinase assays. Strikingly, there is substantial in vitro serine/threonine kinase activity in immunoprecipitates prepared from Fc epsilon R1-activated cells using antisera to the p85 subunit of PI 3-kinase. This activity is inhibited by pretreatment of the cells with wortmannin or by the direct addition of wortmannin to the kinase assay, suggesting that PI 3-kinase itself is capable of acting as a protein kinase. We conclude that Fc epsilon R1 cross-linking activates both lipid and protein kinase activities of PI 3-kinase and that inhibiting these activities with wortmannin results in the selective block of a subset of Fc epsilon R1-mediated signaling responses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8534912      PMCID: PMC301273          DOI: 10.1091/mbc.6.9.1145

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  73 in total

1.  Fc epsilon RI-mediated tyrosine phosphorylation and activation of the 72-kDa protein-tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells.

Authors:  J E Hutchcroft; R L Geahlen; G G Deanin; J M Oliver
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  Complete structure and expression in transfected cells of high affinity IgE receptor.

Authors:  U Blank; C Ra; L Miller; K White; H Metzger; J P Kinet
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

3.  SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange.

Authors:  S Felder; M Zhou; P Hu; J Ureña; A Ullrich; M Chaudhuri; M White; S E Shoelson; J Schlessinger
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

4.  Mass measurements of inositol(1,4,5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: effects of neurotransmitters and depolarization.

Authors:  R A Challiss; I H Batty; S R Nahorski
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

5.  A tyrosine residue in the juxtamembrane segment of the platelet-derived growth factor beta-receptor is critical for ligand-mediated endocytosis.

Authors:  S Mori; L Rönnstrand; L Claesson-Welsh; C H Heldin
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

6.  Inhibition of the phagocytosis-induced respiratory burst by the fungal metabolite wortmannin and some analogues.

Authors:  M Baggiolini; B Dewald; J Schnyder; W Ruch; P H Cooper; T G Payne
Journal:  Exp Cell Res       Date:  1987-04       Impact factor: 3.905

7.  Inhibition of IgE-mediated histamine release by myosin light chain kinase inhibitors.

Authors:  S Kitani; R Teshima; Y Morita; K Ito; Y Matsuda; Y Nonomura
Journal:  Biochem Biophys Res Commun       Date:  1992-02-28       Impact factor: 3.575

8.  Isoprenoid pathway activity is required for IgE receptor-mediated, tyrosine kinase-coupled transmembrane signaling in permeabilized RBL-2H3 rat basophilic leukemia cells.

Authors:  G G Deanin; J R Pfeiffer; J L Cutts; M L Fore; J M Oliver
Journal:  Cell Regul       Date:  1991-08

9.  Depletion of guanine nucleotides with mycophenolic acid suppresses IgE receptor-mediated degranulation in rat basophilic leukemia cells.

Authors:  B S Wilson; G G Deanin; J C Standefer; D Vanderjagt; J M Oliver
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

10.  Membrane and cytoskeletal changes associated with IgE-mediated serotonin release from rat basophilic leukemia cells.

Authors:  J R Pfeiffer; J C Seagrave; B H Davis; G G Deanin; J M Oliver
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

View more
  33 in total

1.  Mutant RBL mast cells defective in Fc epsilon RI signaling and lipid raft biosynthesis are reconstituted by activated Rho-family GTPases.

Authors:  K A Field; J R Apgar; E Hong-Geller; R P Siraganian; B Baird; D Holowka
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 2.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

3.  Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells.

Authors:  T S Manetz; C Gonzalez-Espinosa; R Arudchandran; S Xirasagar; V Tybulewicz; J Rivera
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  Regulation of macropinocytosis by p21-activated kinase-1.

Authors:  S Dharmawardhane; A Schürmann; M A Sells; J Chernoff; S L Schmid; G M Bokoch
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

5.  Exclusion of lipid rafts and decreased mobility of CD94/NKG2A receptors at the inhibitory NK cell synapse.

Authors:  Tolib B Sanni; Madhan Masilamani; Juraj Kabat; John E Coligan; Francisco Borrego
Journal:  Mol Biol Cell       Date:  2004-05-07       Impact factor: 4.138

Review 6.  Rethinking the role of Src family protein tyrosine kinases in the allergic response: new insights on the functional coupling of the high affinity IgE receptor.

Authors:  Yasuko Furumoto; Claudia Gonzalez-Espinosa; Gregorio Gomez; Martina Kovarova; Sandra Odom; Valentino Parravicini; John J Ryana; Juan Rivera
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  Time-resolved three-dimensional molecular tracking in live cells.

Authors:  Nathan P Wells; Guillaume A Lessard; Peter M Goodwin; Mary E Phipps; Patrick J Cutler; Diane S Lidke; Bridget S Wilson; James H Werner
Journal:  Nano Lett       Date:  2010-11-10       Impact factor: 11.189

8.  Nf1-/- Schwann cell-conditioned medium modulates mast cell degranulation by c-Kit-mediated hyperactivation of phosphatidylinositol 3-kinase.

Authors:  Shi Chen; Sarah Burgin; Andrew McDaniel; Xiaohong Li; Jin Yuan; Mia Chen; Waleed Khalaf; D Wade Clapp; Feng-Chun Yang
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

9.  Reaction diffusion modeling of calcium dynamics with realistic ER geometry.

Authors:  Shawn Means; Alexander J Smith; Jason Shepherd; John Shadid; John Fowler; Richard J H Wojcikiewicz; Tomas Mazel; Gregory D Smith; Bridget S Wilson
Journal:  Biophys J       Date:  2006-04-14       Impact factor: 4.033

Review 10.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.